跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,773 条关于
“bevacizumab gamma”
全部
4,773
临床试验
3,655
药物
400
机构
8
资讯
710
去年
LYTENAVA Receives NICE Recommendation for Wet AMD Treatment in the UK
去年
Outlook Therapeutics Launches First Approved Ophthalmic Bevacizumab in Europe for Wet AMD Treatment
去年
Outlook Therapeutics Announces Executive Leadership Transition
去年
ONS-5010 Fails to Meet Non-Inferiority Endpoint in NORSE EIGHT Trial for Wet AMD
2年前
Outlook Therapeutics Advances ONS-5010 Toward Potential First Approved Ophthalmic Bevacizumab for Retinal Diseases
2年前
Outlook Therapeutics Completes Enrollment in NORSE EIGHT Wet AMD Trial
9个月前
Outlook Therapeutics Awaits Critical FDA Decision on First Ophthalmic Bevacizumab for Wet AMD by December 31
去年
Outlook Therapeutics' ONS-5010 Shows Non-Inferiority to Ranibizumab in Wet AMD Trial
去年
Scottish Health Authority Approves Theramex's Abaloparatide for High-Risk Osteoporosis Treatment
去年
Bevacizumab Shows Superior Overall Survival Compared to Aflibercept in RAS Wild-Type Metastatic Colorectal Cancer
第 1 页,共 71 页
上一页
下一页